SYST-02 PHASE ⅡB CLINICAL TRIAL OF NEOADJUVANT CHEMOTHERAPY REVERSING GLIOMA STEM CELLS CHEMORESISTANCE IN NEWLY DIAGNOSED GBM WITH MGMT PROMOTER UNMETHYLATION

PURPOSE: To evaluate clinical efficacy and safety of combination of nicardipine and valproic acid on temozolomide (TMZ) neoadjuvant chemotherapy targeting on glioma stem cells (GSCs) in newly diagnosed glioblastoma multiforme (GBM) patients with O(6)-methylguanine-DNA-methyltransferase (MGMT) promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Jun, Wang, Liping, Chen, Yanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354196/
http://dx.doi.org/10.1093/noajnl/vdac078.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354196/
http://dx.doi.org/10.1093/noajnl/vdac078.081

Ejemplares similares